Ang, Y.-S., Bruder, G. E., Keilp, J. G., Rutherford, A., Alschuler, D. M., Pechtel, P., Webb, C. A., Carmody, T., Fava, M., Cusin, C., McGrath, P. J., Weissman, M., Parsey, R., Oquendo, M. A., McInnis, M. G., Cooper, C. M., Deldin, P., Trivedi, M. H., & Pizzagalli, D. A. (2020). Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. Psychological Medicine, 52(13), 2441–2449. https://doi.org/10.1017/s0033291720004286